There is a lot of unknowns today.

We're going to talk about what experts are saying based on up to date research about the rollout of a covert 19 vaccine over the coming year.

Picture this.

It's September 2021.

Covad, 19 is still being spread across the world.

Let's say 300 million people have been infected.

Two million have died.

These air some predictions for next fall.

You have survived the dark winter you've enjoyed this summer, physically distancing with your friends your kind of used to this pandemic lifestyle of outbreaks and locked down.

Yeah, and a vaccine fork over 19 has been approved, but you do not have access to it yet.

So why is that?

Something that scientists are talking about a lot right now and publishing papers are saying we need glass vials.

Okay, The vaccine is held in glass vials, and I'm not a politician, but I really just like wherever the glass vial factories are, let's start spitting them out.

Another interesting factor is whether or not the vaccine that eventually gets approved needs to be cold.

A lot of vaccines require refrigeration.

This is a huge issue for a lot of the world.

As we all know, the world is hot and it's only getting hotter.

And the necessity of a cold vaccine can hinder the ability to get this vaccine across the world efficiently.

As of September 2020 there are 47 vaccine trials taking place, 24 are in phase 1, 14 are in phase two, and nine are in phase three.

Phase three means that these vaccines have actually been proven safe to test in people.

But we have to test in numbers as high as 20,000 to 40,000 people.

Then we also have to have some in control groups, some not.

Then we have to follow these people for months to a year in following number.

Trying to see is this vaccine provoking in immune response, which protects you from Cove in 19 in early September 2020.

Just last week, the AstraZeneca trial was paused.

This is because one person in Britain who was in the phase 23 trials actually came down with a inflammation of their spinal core.

This is a very important story because it's showing that there is a healthy process at work here.

In fact, nine of the top bio pharmaceutical companies in the same week sent out a letter to say that even though they are essentially business rivals, they will be working together to ensure that scientific standards and ethical treatment of people when it comes to the actual administering of these Phase three trials and the concept of approving a vaccine will be held to the highest standards.

This is interesting because when the vaccine is approved, there are still gonna be governing regulations that decide whether or not that vaccine gets into your country.

So in America you have something like the FDA.

Here in Canada, we have Health Canada and all of the phase three trials that they're currently doing the information will be public.

So governing bodies will still be able to see why that vaccine might have been approved from a scientific process and decide if they think as a government that it is ready to come into their country.

So when it comes to you getting your vaccine, there is going to be companies going through Phase three trials with public scientific knowledge to decide whether or not that vaccine is safe for you.

But then also, there will be your own government making a decision whether or not that vaccine is safe for you.

So thinking about timeline, it's just important to know that these Phase three trials were following these people for months to a year.

So this is one of the reasons why, maybe next year in September 2021 you're still going to be chilling and locked down.

But let's move on to some other factors that also may slow down this process.

The first vaccine that is approved may not be the most efficient.

It may not be the one that you end up getting because, for example, another vaccine might get approved.

That doesn't need to be refrigerated.

Therefore, it is a more efficient vaccine.

The first vaccine approved May Onley cause immunity for six months and need booster shots, whereas another vaccine again create a better or more strong immune response within people.

There are also some interesting vaccine potentials that might involve just topical applications, which again would be even more efficient.

So one other important part of this is that the first approved vaccine doesn't mean that we stop all the other trials.

The other trials need to continue because the most efficient vaccine may not be the first approved.

So once approved, how many of these vaccines are we going to need in order to halt transmission of the virus within a population?

It's expected that 60 to 70% of that population needs to be immune.

But that's still not going to prevent Koster's of outbreaks within people who are susceptible to the virus.

For example, the largest vaccine producer is in India, called the Serum Institute of India.

It's in puny, and they can create 60 to 70 million vaccines.

Pirmin AstraZeneca actually has a relationship with the specific factories to make one billion of their potential vaccines.

The United States Canada, U, United Kingdom.

They have all ordered already million's of vaccines from a variety of manufacturers, enough to produce vaccines for their populations over and over and over.

Which brings us to an important part of this conversation, which is that wealthier countries are likely going to have more access to these vaccines.

The fact that a lot of these manufacturing processes are linked with the capitalist idea of wealthy countries being able to bid the highest for the vaccine.

We need to talk about this.

I think be prepared for what is gonna happen in regards to this So we can understand how we have conversations about this in the coming year because the wealthier countries need to figure out how we can also support people in other countries who maybe don't have the money to get their hands on the vaccine.

First, the idea that countries are gonna buy and have a vaccine first can lead to something called vaccine nationalism.

And a lot of people are coming together.

Ethicists, scientists to try and figure out codes of conduct and actually think about it from a administrative level how we can share this vaccine, because if there's one thing that we've learned in the process of going through a global pandemic, is that your only as strong as your weakest link, The W.

H.

O.

Is suggesting that we give the vaccine to countries based on their population, starting with 3% of their population and moving towards 20% of their population across the world, starting with healthcare workers and people who are over 65 some other administrative policies air thinking, Why don't we just focus on how many people are above 65 populations how maney healthcare workers there are and just inoculate them in every country.

But again, this is interesting, because from a socioeconomic perspective, wealthier countries actually have more health care workers, and they actually have older populations.

So then again, are we leaving non wealthier countries out?

This has led to something called the Fair Priority model, which is designed by ethicists and scientists.

And it's a code of conduct that we can talk to politicians and you can now understand toe.

Place yourself in 2021 when these conversations are starting to happen.

The fair priority model is designed to limit harm, prioritize the disadvantaged and give equal moral concern to all individuals.

The need for this type of document and concept is because, inevitably, wealthy nations are going to end up with the vaccine first.

So right now there are a lot of international organizations G 20 leaders coming together to figure out how they could not draw lines in the sand with borders when it comes to how we bring this vaccine to the world.

In fact, many people are applauding India right now, as a country that makes so many vaccines, they are already figuring out how they can set enough aside for people in nations that will need them.

Many of these manufacturing companies are going to be thinking about the highest bidder when it comes to administering the vaccine.

But I think it's important that we understand how many have been ordered from Canada and America more than the population.

So we have to make sure we aren't hoarding these things and understanding that the world is becoming too cove in 19 not just the countries that we live in.

And no matter what country you are in, there's going to be a focus on individuals who are over 65 healthcare workers, teachers and the immuno compromised first before the general public is administered with the vaccine.

And so for these reasons, there is a good chance that next year we'll have an approved vaccine, but you might not have got it.

But that doesn't mean that we're not going to be well on our way to inoculating the world or at least getting some of these systems in place to figure out how we're going to do it and We also just may be totally wrong.

Something else could happen again.

This is also unknown.

This is just based on the most current up to date research about how this vaccine will be administered.

I personally I'm obsessed with this information because it gives me Solis.

It kind of helps me be a little bit more at peace to sort of understand what experts are saying, what the smartest people in the room are saying and to prepare myself for what to expect.

For example, maybe not getting a vaccine for another year in order to plan my life.

Now some people, I think ignorance is bliss.

I have friends asked me about the vaccine, and when I tell them this information there, like I wish I didn't know that.

So it's not for everyone.

But if you know people in your life who you think would appreciate the preparation or at least this understanding, feel free to share this with them.

Either way, this is fascinating world changing information that is going to be necessary as we figure out how to bring a vaccine to the world for a global pandemic.